1. Home
  2. NSPR vs SQNS Comparison

NSPR vs SQNS Comparison

Compare NSPR & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.85

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$2.79

Market Cap

46.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
SQNS
Founded
2005
2003
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
46.9M
IPO Year
2009
2011

Fundamental Metrics

Financial Performance
Metric
NSPR
SQNS
Price
$0.85
$2.79
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.00
$20.33
AVG Volume (30 Days)
87.8K
30.5K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
$49.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$2.38
52 Week High
$2.57
$10.93

Technical Indicators

Market Signals
Indicator
NSPR
SQNS
Relative Strength Index (RSI) 50.26 44.40
Support Level $0.66 $2.72
Resistance Level $1.00 $3.20
Average True Range (ATR) 0.08 0.13
MACD -0.01 -0.02
Stochastic Oscillator 15.53 14.61

Price Performance

Historical Comparison
NSPR
SQNS

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

Share on Social Networks: